The role of calcium, phosphorus and vitamin D metabolism in the development of secondary hyperparathyroidism

Nephrology Dialysis Transplantation

Volumn 13, Issue SUPPL. 3, 1998, Pages 3-8

  Slatopolsky, Eduardo ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calcium; Phosphorus; Renal osteodystrophy; Secondary hyperparathyroidism; Vitamin D

Indexed keywords

CALCIUM ION; PARATHYROID HORMONE; PHOSPHORUS; VITAMIN D;

CALCIUM METABOLISM; CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; FEEDBACK SYSTEM; HUMAN; PHOSPHATE METABOLISM; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY; SECONDARY HYPERPARATHYROIDISM; VITAMIN D METABOLISM;

EID: 0031977381     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.suppl_3.3     Document Type: Conference Paper

References (36)

1. 2+-sensing receptor from bovine parathyroid. Nature 1993; 366: 575-580
2. 2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 1993; 75: 1297-1303
3. 3, Endocrinology 1995; 136: 499-504
4. Brown AJ, Zhong M, Finch J et al. Rat calcium-sensing receptor is regulated by vitamin D but not calcium. Am J Physiol 1996; 270: F454-F460
5. Brown AJ, Zhong M, Ritter C, Brown EM, Slatopolsky E. Loss of calcium responsiveness in cultured bovine parathyroid cells is associated with decreased calcium receptor expression. Biochem Biophys Res Commun 1995; 212: 861-867
6. 3. Endocrinology 1989; 125: 275-280
7. Yamamoto M, Igarashi T, Muramatsu M, Fukagawa M, Motokura T, Ogata E. Hypocalcemia increases and hypercalcemia decreases the steady-state level of parathyroid hormone messenger RNA in the rat. J Clin Invest 1989; 83: 1053-1056
8. Okazaki T, Zajac JD, Igarashi T, Ogata E, Kronenberg HM. Negative regulatory elements in the human parathyroid hormone gene. J Biol Chem 1991; 266: 21903-21910
9. Bellorin-Font E, Martin KJ, Freitag JJ, Slatopolsky E. Altered adenylate cyclase kinetics in hyperfunctioning human parathyroid glands. J Clin Endocrinol Metab 1981; 52: 499-507
10. Brown EM, Wilson RE, Thatcher JG, Marynick SP. Abnormal calcium regulated PTH release in normal parathyroid tissue from patients with adenoma. Am J Med 1981; 71: 565-571
11. Kifor O, Moore FD, Wang P et al. Reduced immunostaining for the extracellular Ca sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab 1996; 81: 1598-1606
12. Portale AA, Booth BE, Halloran BP, Morris RC Jr. Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency. J Clin Invest 1987; 73: 1580-1589
13. Lopez-Hilker S, Dusso A, Rapp N, Martin K, Slatopolsky E. Phosphorus restriction reverses secondary hyperparathyroidism in chronic renal failure independent of changes in calcium and 1,25 dihydroxycholecalciferol. Am J Physiol 1990; 259: F432-F437
14. Lucas PA, Brown RC, Woodhead JS, Coles GA. 1,25-Dihydroxycholecalciferol and parathyroid hormone in advanced chronic renal failure: effects of simultaneous protein and phosphorus restriction. Clin Nephrol 1986; 25: 7-10
15. Schaefer K, Erley CM, von Herrath D, Stein G. Calcium salts of ketoacids as a new treatment strategy for uremic hyperphos-phatemia. Kidney Int 1989; 36: S136-S139
16. Dabbagh S, Chesney R, Gusowski N et al. Amino aciduria of vitamin D deficiency is independent of PTH levels and urinary cyclic AMP. Miner Electrolyte Metab 1989; 15: 221-232
17. Slatopolsky E, Finch J, Denda M et al. Phosphorus restriction prevents parathyroid gland growth: high phosphorus directly stimulates PTH secretion in vitro. J Clin Invest 1996; 97: 2534-2540
18. Kilav R, Silver J, Navey-Many T. Parathyroid hormone gene expression in hypophosphatemic rats. J Clin Invest 1995; 96: 327-33
19. Naveh-Nany T, Rahaminov R, Livni N, Silver J. Parathyroid cell proliferation in normal and chronic renal failure. The effects of calcium, phosphate and vitamin D. J Clin Invest 1995; 96: 1786-1793
20. Yi H, Fukagawa M, Yamato H, Kumagai M, Watanabe T, Kurokawa K. Prevention of enhanced parathyroid hormone secretion, synthesis and hyperplasia by mild dietary phosphorus restriction in early chronic renal failure in rats: possible direct role of phosphorus. Nephron 1995; 70: 242-248
21. Almaden Y, Canalejo A, Hernandez A et al. Direct effect of phosphorus on PTH secretion from whole rat parathyroid glands in vitro. J Bone Miner Dis 1996; 11: 970-976
22. 3 in the parathyroid glands of patients with renal failure. New Engl J Med 1987; 315: 1573-1577
23. 3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 1993; 92: 1436-1443
24. 3 receptors in experimental uremia. Kidney Int 1987; 32: 3350-3353
25. 3 receptors are decreased in parathyroid glands from chronically uremic dogs. Kidney Int 1989; 35: 19-23
26. 9k in uraemic rats. Eur J Clin Invest 1991; 21: 521-526
27. 3 and 22-oxacalcitriol prevent the decrease in vitamin D receptor content in the parathyroid glands of uremic rats. Kidney Int 1996; 50: 34-39
28. Shvil Y, Naveh-Many T, Barach P, Silver J. Regulation of parathyroid cell gene expression in experimental uremia. J Am Soc Nephrol 1990; 1: 99-104
29. Patel SR, Ke HQ, Vanholder R, Hsu CH. Inhibition of nuclear uptake of calcitriol receptor by uremic ultrafiltrate. Kidney Int 1994; 46: 129-133
30. Patel SR, Ke HQ, Vanholder R, Koenig RJ, Hsu CH. Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins. J Clin Invest 1995; 96: 50-59
31. Patel SR, Ke HW, VanHolder R, Koening R, Hsu C. Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins. J Clin Invest 1995; 96: 50-59
32. Silver J, Naveh-Many T. Regulation of parathyroid hormone synthesis and secretion. Semin Nephrol 1994; 14: 175-194
33. 3. Proc Natl Acad Sci USA 1992; 89: 8097-8101
34. 3 and binds the vitamin D receptor. Mol Endocrinol 1996; 10: 206-215
35. 3 in the regulation of vitamin D receptor expression by rat parathyroid glands. Endocrinology 1995; 136: 1419-1425
36. 3 pulse therapy. Miner Electrolyte Metab 1995; 21: 223-228